Muscarinic receptor agonists and antagonists

被引：69
作者：
Broadley, KJ
Kelly, DR
机构：
[1] Cardiff Univ, Welsh Sch Pharm, Div Pharmacol, Cardiff CF10 3TB, S Glam, Wales
[2] Cardiff Univ, Dept Chem, Cardiff CF10 3TB, S Glam, Wales
来源：
MOLECULES | 2001年 / 6卷 / 03期
关键词：
Alzheimer's disease; nicotine; acetylcholine; arecoline; himbacine; tacrine; cyclostelletamines; intramolecular Diels-Alder reaction; indole alkaloids;
D O I：
10.3390/60300142
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholine agonists and antagonists is presented. The therapeutic benefits of achieving receptor subtype selectivity are outlined and applications in the treatment of Alzheimer's disease are discussed. A selection of chemical routes are described, which illustrate contemporary methodology for the synthesis of chiral medicinal compounds (asymmetric synthesis, chiral pool, enzymes). Routes to bicyclic intrannular amines and intramolecular Diels-Alder reactions are highlighted.
引用
收藏
页码：142 / 193
页数：52
相关论文
共 204 条
[61]   ENANTIOSPECIFIC SYNTHESIS OF S-QUINUCLIDINOL FROM D-GLUCOSE - A STRATEGY FOR THE SYNTHESIS OF CHIRAL QUINUCLIDINES [J].
FLEET, GWJ ;
JAMES, K ;
LUNN, RJ .
TETRAHEDRON LETTERS, 1986, 27 (26) :3053-3056
[62]   Some progeny of 2,3-unsaturated sugars - They little resemble grandfather glucose: Twenty years later [J].
FraserReid, B .
ACCOUNTS OF CHEMICAL RESEARCH, 1996, 29 (02) :57-66
[63]   THE DESIGN OF NOVEL MUSCARINIC PARTIAL AGONISTS THAT HAVE FUNCTIONAL SELECTIVITY IN PHARMACOLOGICAL PREPARATIONS INVITRO AND REDUCED SIDE-EFFECT PROFILE INVIVO [J].
FREEDMAN, SB ;
DAWSON, GR ;
IVERSEN, LL ;
BAKER, R ;
HARGREAVES, RJ .
LIFE SCIENCES, 1993, 52 (5-6) :489-495
[64]   INVIVO CHARACTERIZATION OF NOVEL EFFICACIOUS MUSCARINIC RECEPTOR AGONISTS [J].
FREEDMAN, SB ;
HARLEY, EA ;
MARWOOD, RS ;
PATEL, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (02) :193-199
[65]   A NOVEL SERIES OF NONQUATERNARY OXADIAZOLES ACTING AS FULL AGONISTS AT MUSCARINIC RECEPTORS [J].
FREEDMAN, SB ;
HARLEY, EA ;
PATEL, S ;
NEWBERRY, NR ;
GILBERT, MJ ;
MCKNIGHT, AT ;
TANG, JK ;
MAGUIRE, JJ ;
MUDUNKOTUWA, NT ;
BAKER, R ;
STREET, LJ ;
MACLEOD, AM ;
SAUNDERS, J ;
IVERSEN, LL .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :575-580
[66]   L-687,306 - A FUNCTIONALLY SELECTIVE AND POTENT MUSCARINIC M1-RECEPTOR AGONIST [J].
FREEDMAN, SB ;
PATEL, S ;
HARLEY, EA ;
IVERSEN, LL ;
BAKER, R ;
SHOWELL, GA ;
SAUNDERS, J ;
MCKNIGHT, A ;
NEWBERRY, N ;
SCHOLEY, K ;
HARGREAVES, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (01) :135-136
[67]  
Frey KA, 1998, Q J NUCL MED, V42, P166
[68]   CYCLOSTELLETTAMINES-A-F, PYRIDINE ALKALOIDS WHICH INHIBIT BINDING OF METHYL QUINUCLIDINYL BENZILATE (QNB) TO MUSCARINIC ACETYLCHOLINE-RECEPTORS, FROM THE MARINE SPONGE, STELLETTA-MAXIMA [J].
FUSETANI, N ;
ASAI, N ;
MATSUNAGA, S ;
HONDA, K ;
YASUMURO, K .
TETRAHEDRON LETTERS, 1994, 35 (23) :3967-3970
[69]   Intramolecular Diels-Alder reactions of 3-(tetrahydropyridinyl)indoles: Stereoselective synthesis of novel pentacyclic ring systems [J].
Gharagozloo, P ;
Miyauchi, M ;
Birdsall, B ;
Birdsall, NJM .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (06) :1974-1980
[70]   Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications [J].
Giacobini, E .
NEUROCHEMISTRY INTERNATIONAL, 1998, 32 (5-6) :413-419
234567891011